-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

Benzinga·04/21/2026 15:42:55
Listen to the news
Canaccord Genuity analyst Gary Nachman initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $13.